Chargement en cours...
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Gastric cancer (GC) is the fifth most common cancer worldwide. Despite recent improvements in treatment quality and options, advanced gastric cancer remains one of the hardest to cure cancers, with a median overall survival (OS) of 10–12 months and a 5-year OS of approximately 5–20%. There is an unm...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286155/ https://ncbi.nlm.nih.gov/pubmed/34285507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S315252 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|